RIAS
NKTR icon

Rachor Investment Advisory Services’s Nektar Therapeutics NKTR Stock Holding History

Rachor Investment Advisory Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41
Closed -$2.95K – 340
2026
Q1 		$2.95K Buy
41
+6
+17% +$342 ﹤0.01% 210
2025
Q4 		$1.48K Buy
+35
New +$1.96K ﹤0.01% 273

Other funds holding NKTR

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
G
Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
LA
LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Rachor Investment Advisory Services's NKTR Position: Q2 2026 in Review

Rachor Investment Advisory Services sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 41 shares — an estimated $2.95K sold.

Rachor Investment Advisory Services first reported a position in NKTR in Q4 2025 and held it in 2 quarters. The position peaked at $2.95K in Q1 2026. 11 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Rachor Investment Advisory Services reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rachor Investment Advisory Services sold 41 Nektar Therapeutics shares in Q2 2026, an estimated $2.95K.
  • Rachor Investment Advisory Services first reported a position in Nektar Therapeutics in Q4 2025 and held it in 2 quarters.
  • Rachor Investment Advisory Services's Nektar Therapeutics position peaked at $2.95K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.